Literature DB >> 6133549

Metabolism of 4-pentenoic acid and inhibition of thiolase by metabolites of 4-pentenoic acid.

H Schulz.   

Abstract

The metabolism of 4-pentenoic acid, a hypoglycemic agent and inhibitor of fatty acid oxidation, has been studied in rat heart mitochondria. Confirmed was the conversion of 4-pentenoic acid to 2,4-pentadienoyl coenzyme A (CoA), which either is directly degraded via beta-oxidation or is first reduced in a NADPH-dependent reaction before it is further degraded by beta-oxidation. At pH 6.9, the NADPH-dependent reduction of 2,4-pentadienoyl-CoA proceeds 10 times faster than its degradation by beta-oxidation. At pH 7.8, this ratio is only 2 to 1. The direct beta-oxidation of 2,4-pentadienoyl-CoA leads to the formation of 3-keto-4-pentenoyl-CoA, which is highly reactive and spontaneously converts to another 3-ketoacyl-CoA derivative (compound X). 3-Keto-4-pentenoyl-CoA is a poor substrate of 3-ketoacyl-CoA thiolase (EC 2.3..1.16) whereas compound X is not measurably acted upon by this enzyme. The effects of several metabolites of 4-pentenoic acid on the activity of 3-ketoacyl-CoA thiolase were studied. 3,4-Pentadienoyl-CoA is a weak inhibitor of this enzyme that is protected against the inhibition by acetoacetyl-CoA. The most effective inhibitor of 3-ketoacyl-CoA thiolase was found to be 3-keto-4-pentenoyl-CoA, which inhibits the enzyme in both a reversible and irreversible manner. The reversible inhibition is possibly a consequence of the inhibitor being a poor substrate of 3-ketoacyl-CoA thiolase. It is concluded that 4-pentenoic acid is metabolized in mitochondria by two pathways. The minor yields 3-keto-4-pentenoyl-CoA, which acts both as a reversible and as a irreversible inhibitor of 3-ketoacyl-CoA thiolase and consequently of fatty acid oxidation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6133549     DOI: 10.1021/bi00277a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Noncovalent interactions dominate dynamic heme distortion in cytochrome P450 4B1.

Authors:  Gareth K Jennings; Mei-Hui Hsu; Lisa S Shock; Eric F Johnson; John C Hackett
Journal:  J Biol Chem       Date:  2018-06-01       Impact factor: 5.157

2.  Genetic and molecular characterization of the genes involved in short-chain fatty acid degradation in Escherichia coli: the ato system.

Authors:  L S Jenkins; W D Nunn
Journal:  J Bacteriol       Date:  1987-01       Impact factor: 3.490

3.  Accumulation of polyhydroxyalkanoic acid containing large amounts of unsaturated monomers in Pseudomonas fluorescens BM07 utilizing saccharides and its inhibition by 2-bromooctanoic acid.

Authors:  H J Lee; M H Choi; T U Kim; S C Yoon
Journal:  Appl Environ Microbiol       Date:  2001-11       Impact factor: 4.792

4.  Potentiation by ammonia of the metabolic effects of pent-4-enoate in isolated rat hepatocytes.

Authors:  F X Coudé; G Grimber; P Parvy; D Rabier; J Bardet
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

Review 5.  Metabolism of valproate to hepatotoxic intermediates.

Authors:  T A Baillie
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

6.  Formation of poly(hydroxybutyrate-co-hydroxyvalerate) by Azotobacter vinelandii UWD.

Authors:  W J Page; J Manchak; B Rudy
Journal:  Appl Environ Microbiol       Date:  1992-09       Impact factor: 4.792

7.  Protection of rats by clofibrate against the hypoglycaemic and toxic effects of hypoglycin and pent-4-enoate. An ultrastructural and biochemical study.

Authors:  F Van Hoof; L Hue; J Vamecq; H S Sherratt
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

8.  Establishing individual metabolite patterns for patients on valproate therapy.

Authors:  U Kreher; J Darius; F Wien
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.569

9.  Identification and Quantification of Glutathionylated Cysteines under Ischemic Stress.

Authors:  Maheeshi Yapa Abeywardana; Kusal T G Samarasinghe; Dhanushka Munkanatta Godage; Young-Hoon Ahn
Journal:  J Proteome Res       Date:  2021-08-12       Impact factor: 5.370

10.  Bioorthogonal pro-metabolites for profiling short chain fatty acylation.

Authors:  Wilson R Sinclair; Jonathan H Shrimp; Thomas T Zengeya; Rhushikesh A Kulkarni; Julie M Garlick; Hans Luecke; Andrew J Worth; Ian A Blair; Nathaniel W Snyder; Jordan L Meier
Journal:  Chem Sci       Date:  2017-12-08       Impact factor: 9.825

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.